- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00353353
The Bread Trial: Effects of Bread Fortified With Folic Acid and Vitamin B12
July 6, 2007 updated by: Wageningen Centre for Food Sciences
The Bread Trial: a Demonstration Trial to Show Effects of Fortification of Food With Both Folic Acid and Vitamin B12
In the Netherlands fortification of food products is not yet mandatory.
One of the major arguments of the Dutch Health Council to advise against mandatory fortification is the possibility of masking of a vitamin B12 deficiency.
A possible solution to overcome the possibility of masking is: fortification of foods with both folic acid and vitamin B12.
In this study we want to assess the effects of this fortification strategy on markers of folate and vitamin B12 status.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
During a 12 week period subjects will consume
- bread fortified with folic acid and vitamin B12 or
- placebo bread (not fortified)
Bread consumption has to be at least 3 slices per day, fortification level is 100mcg folic acid and 6mcg vitamin B12 per 3 slices.
We will study the effect of this fortification strategy on markers of folate and vitamin B12 status.
Study Type
Interventional
Enrollment (Anticipated)
150
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Wageningen, Netherlands, 6700HD
- Wageningen University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
50 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- age 50-75y
Exclusion Criteria:
- consumption of < 3 slices of bread/day
- use of B-vitamins in the period three months prior to the study
- treatment with B12-injections in the last 5y
- illness or use of medication interfering with folate or vitamin B12 metabolism
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
|---|
|
serum B12 status
|
|
serum folate status
|
Secondary Outcome Measures
Outcome Measure |
|---|
|
erythrocyte folate;
|
|
homocysteine;
|
|
MMA;
|
|
holoTC
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Petra Verhoef, PhD, Wageningen University
- Principal Investigator: Ingeborg Brouwer, PhD, Wageningen University
- Principal Investigator: Martijn Katan, Professor, Wageningen University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2006
Study Completion (Actual)
December 1, 2006
Study Registration Dates
First Submitted
July 17, 2006
First Submitted That Met QC Criteria
July 17, 2006
First Posted (Estimate)
July 18, 2006
Study Record Updates
Last Update Posted (Estimate)
July 9, 2007
Last Update Submitted That Met QC Criteria
July 6, 2007
Last Verified
July 1, 2007
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 06/02
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.